These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20406313)

  • 21. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrollment Patterns of Medicare Advantage Beneficiaries by Dental, Vision, and Hearing Benefits.
    Gupta A; Silver D; Meyers DJ; Murray G; Glied S; Pagán JA
    JAMA Health Forum; 2024 Jan; 5(1):e234936. PubMed ID: 38214919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simplifying The Medicare Plan Finder Tool Could Help Older Adults Choose Lower-Cost Part D Plans.
    McGarry BE; Maestas N; Grabowski DC
    Health Aff (Millwood); 2018 Aug; 37(8):1290-1297. PubMed ID: 30080456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO; Frank RG; McWilliams JM
    JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of satisfaction and switching costs in Medicare Part D choices.
    Han J; Ko DW; Urmie JM
    Res Social Adm Pharm; 2014; 10(2):398-407. PubMed ID: 23988694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric properties of an instrument to assess Medicare beneficiaries' prescription drug plan experiences.
    Martino SC; Elliott MN; Cleary PD; Kanouse DE; Brown JA; Spritzer KL; Heller A; Hays RD
    Health Care Financ Rev; 2009; 30(3):41-53. PubMed ID: 19544934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Part D beneficiaries' incentives and responses under preferred pharmacy networks.
    Xu J; Trish E; Joyce G
    Am J Manag Care; 2023 Apr; 29(4):180-186. PubMed ID: 37104832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use.
    Fung V; Price M; Cheng D; Patel TA; Yang Z; Hsu J; Alegria M; Newhouse JP
    JAMA Health Forum; 2024 Feb; 5(2):e235152. PubMed ID: 38306091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative exploration of factors influencing the plan selection process by Medicare beneficiaries.
    Zhao Y; Diggs K; Chen ZX; Hohmann N; Kwon WS; Westrick SC
    J Manag Care Spec Pharm; 2021 Mar; 27(3):339-353. PubMed ID: 33645247
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Part D plan enrollment by uninsured medicare beneficiaries.
    Maciejewski ML; Farley JF; Hansen RA; Wei D; Harman JS
    Med Care; 2010 Feb; 48(2):183-6. PubMed ID: 20057332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government.
    Trish E; Kaiser KM; Celestin J; Joyce G
    J Health Polit Policy Law; 2022 Dec; 47(6):853-877. PubMed ID: 35867529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
    Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
    J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of benefits, premiums, and health risk on health plan choice in the Medicare program.
    Atherly A; Dowd BE; Feldman R
    Health Serv Res; 2004 Aug; 39(4 Pt 1):847-64. PubMed ID: 15230931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Donohue JM; Frank RG
    Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Policy implications of Medicare Part D for adults with mental illness: a qualitative exploration.
    Hensley MA
    Soc Work Public Health; 2012; 27(3):238-49. PubMed ID: 22486429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.